“Cleaning verification is a critical step in the drug manufacturing process, and Pfizer is committed to the development of technologies that could decrease inspection times, reduce costs and improve supply assurance,” said Steve Hammond, head of the Process Analytical Sciences Group and senior director in the Global Manufacturing Services organization at Pfizer.

The novel approach is expected to reduce labor, material and consumables in addition to plant downtime.

“Block’s QCL-based infrared spectrometers are opening new markets, and cleaning verification is one of the most exciting and high-impact applications,” said Block Engineering CEO Petros Kotidis.